Mark Holt Selected Research

Early-Onset Myopathy with Fatal Cardiomyopathy

6/2008

Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Holt Research Topics

Disease

3	Muscular Diseases (Myopathy) 01/2021 - 06/2008
2	Wounds and Injuries (Trauma) 11/2019 - 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2014
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 06/2008
1	Type 2J Limb-Girdle Muscular Dystrophy 06/2008
1	Early-Onset Myopathy with Fatal Cardiomyopathy 06/2008

Drug/Important Bio-Agent (IBA)

3	ConnectinIBA 01/2021 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2008
1	ActomyosinIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	CollagenIBA 01/2015
1	Ataxin-1IBA 01/2014
1	polyglutamineIBA 01/2014

Therapy/Procedure

1	Orthopedic Procedures 11/2019
1	Oral Surgery (Maxillofacial Surgery) 01/2018